Bactolife
Seedtable Score
44
Startups
2
Funding Rounds
2
Investors
$41.22m
Money raised
Overview
Bactolife, based in Copenhagen, shows strong potential in the biotech and pharmaceutical sectors. By producing gut health binding proteins, Bactolife addresses gut health issues more effectively than probiotics, prebiotics, dietary changes, or medications. This technology can significantly improve patient outcomes by offering a precise method to tackle various gut health problems. With backing from entities like the Bill & Melinda Gates Foundation and Novo A/S, Bactolife is well-positioned for substantial market impact. Their B2B model indicates a focus on forming robust industry partnerships, enhancing growth prospects.
- Website: https://bactolife.com
- Business model: b2b
- Company size: 1 - 11 employees
- Headquarters: Copenhagen, Denmark
- Founded: 2017
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (2)
Funding
Funding series
Funding Series Analysis
The company Bactolife has raised a total of $41.22m in funding over 2 rounds.
Key Insights:
- Seed: $8.42m
- Series A: $32.8m
Bactolife Seed (2021, $8M)
$8.42m
Bactolife Series A (2023, $32M)
$32.8m